Diffuse erythematous rash after teneligliptin therapy: A case report

We report a yet unreported, adverse effect of teneligliptin [Dipeptidyl peptidase IV inhibitor (DPP IV)] presenting as diffuse pruritic erythematous rash, in a patient, 2 days after initiation of the drug. The rash waned off after the discontinuation of the drug without any residual lesion.

Detalles Bibliográficos
Autores principales: Agrawal, Prabhat, Jain, Apoorv, Bansal, Saurabh, Raj, Abhishek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293926/
https://www.ncbi.nlm.nih.gov/pubmed/30613561
http://dx.doi.org/10.4103/jfmpc.jfmpc_283_18
_version_ 1783380646277677056
author Agrawal, Prabhat
Jain, Apoorv
Bansal, Saurabh
Raj, Abhishek
author_facet Agrawal, Prabhat
Jain, Apoorv
Bansal, Saurabh
Raj, Abhishek
author_sort Agrawal, Prabhat
collection PubMed
description We report a yet unreported, adverse effect of teneligliptin [Dipeptidyl peptidase IV inhibitor (DPP IV)] presenting as diffuse pruritic erythematous rash, in a patient, 2 days after initiation of the drug. The rash waned off after the discontinuation of the drug without any residual lesion.
format Online
Article
Text
id pubmed-6293926
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-62939262019-01-04 Diffuse erythematous rash after teneligliptin therapy: A case report Agrawal, Prabhat Jain, Apoorv Bansal, Saurabh Raj, Abhishek J Family Med Prim Care Case Report We report a yet unreported, adverse effect of teneligliptin [Dipeptidyl peptidase IV inhibitor (DPP IV)] presenting as diffuse pruritic erythematous rash, in a patient, 2 days after initiation of the drug. The rash waned off after the discontinuation of the drug without any residual lesion. Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC6293926/ /pubmed/30613561 http://dx.doi.org/10.4103/jfmpc.jfmpc_283_18 Text en Copyright: © 2018 Journal of Family Medicine and Primary Care http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Case Report
Agrawal, Prabhat
Jain, Apoorv
Bansal, Saurabh
Raj, Abhishek
Diffuse erythematous rash after teneligliptin therapy: A case report
title Diffuse erythematous rash after teneligliptin therapy: A case report
title_full Diffuse erythematous rash after teneligliptin therapy: A case report
title_fullStr Diffuse erythematous rash after teneligliptin therapy: A case report
title_full_unstemmed Diffuse erythematous rash after teneligliptin therapy: A case report
title_short Diffuse erythematous rash after teneligliptin therapy: A case report
title_sort diffuse erythematous rash after teneligliptin therapy: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293926/
https://www.ncbi.nlm.nih.gov/pubmed/30613561
http://dx.doi.org/10.4103/jfmpc.jfmpc_283_18
work_keys_str_mv AT agrawalprabhat diffuseerythematousrashafterteneligliptintherapyacasereport
AT jainapoorv diffuseerythematousrashafterteneligliptintherapyacasereport
AT bansalsaurabh diffuseerythematousrashafterteneligliptintherapyacasereport
AT rajabhishek diffuseerythematousrashafterteneligliptintherapyacasereport

Ejemplares similares